Targeting Phosphatidylinositol 4-Kinase IIIα for Radiosensitization: A Potential Model of Drug Repositioning Using an Anti-Hepatitis C Viral Agent
- 1 November 2016
- journal article
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 96 (4) , 867-876
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Radiosensitization with combined use of olaparib and PI-103 in triple-negative breast cancerBMC Cancer, 2015
- Protein Kinase C (PKC) Isozymes and CancerNew Journal of Science, 2014
- Enhanced cytotoxic effect of radiation and temozolomide in malignant glioma cells: targeting PI3K-AKT-mTOR signaling, HSP90 and histone deacetylasesBMC Cancer, 2014
- Phosphatidylinositol 4-kinases, phosphatidylinositol 4-phosphate and cancerCancer Letters, 2012
- Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral ActivityPLOS Pathogens, 2012
- Targeting HER2 signaling pathway for radiosensitization: Alternative strategy for therapeutic resistanceCancer Biology & Therapy, 2009
- Class III Phosphatidylinositol 4-Kinase Alpha and Beta Are Novel Host Factor Regulators of Hepatitis C Virus ReplicationJournal of Virology, 2009
- Phosphoinositides in cell regulation and membrane dynamicsNature, 2006
- Vasculogenic Mimicry and Tumor AngiogenesisThe American Journal of Pathology, 2000
- Radiosensitization and Inhibition of Deoxyribonucleic Acid Repair in Rat Glioma Cells by Long-Term Treatment with 12-O-Tetradecanoylphorbol 13-AcetateNeurosurgery, 1993